Search research articles
Contact Us
Filters
Showing results (51-60 of 55) with videos related to
Page
of 6
Sort By:
You have reached the last page of results.
This site can display upto 55 results.
JAMA
|
April 4, 1990
Physician reporting of adverse drug reactions. Results of the Rhode Island Adverse Drug Reaction Reporting Project
H D Scott, A Thacher-Renshaw, S E Rosenbaum, et al.
Journal of the American Academy of Dermatology
|
May 20, 1998
Effect of onychomycosis on quality of life
L A Drake, R K Scher, E B Smith, et al.
Rhode Island Medical Journal
|
July 1, 1987
Rhode Island physicians' recognition and reporting of adverse drug reactions
H D Scott, S E Rosenbaum, W J Waters, et al.
Transfusion
|
March 1, 1986
Results of nationwide screening of blood and plasma for antibodies to human T-cell lymphotrophic III virus, type III
J N Kuritsky, S C Rastogi, G A Faich, et al.
Journal of the National Cancer Institute
|
April 1, 1992
Clustering of adverse drug events: analysis of risk factors for cerebellar toxicity with high-dose cytarabine
H M Jolson, L Bosco, M G Bufton, et al.
Page
of 6
Search research articles
Search
Showing results (51-60 of 55) with videos related to
Sort By:
Page
of 6
You have reached the last page of results.
This site can display upto 55 results.
JAMA
|
April 4, 1990
Physician reporting of adverse drug reactions. Results of the Rhode Island Adverse Drug Reaction Reporting Project
H D Scott, A Thacher-Renshaw, S E Rosenbaum, et al.
Journal of the American Academy of Dermatology
|
May 20, 1998
Effect of onychomycosis on quality of life
L A Drake, R K Scher, E B Smith, et al.
Rhode Island Medical Journal
|
July 1, 1987
Rhode Island physicians' recognition and reporting of adverse drug reactions
H D Scott, S E Rosenbaum, W J Waters, et al.
Transfusion
|
March 1, 1986
Results of nationwide screening of blood and plasma for antibodies to human T-cell lymphotrophic III virus, type III
J N Kuritsky, S C Rastogi, G A Faich, et al.
Journal of the National Cancer Institute
|
April 1, 1992
Clustering of adverse drug events: analysis of risk factors for cerebellar toxicity with high-dose cytarabine
H M Jolson, L Bosco, M G Bufton, et al.
Page
of 6